pharmacogenetic testing
Estimating cost savings of pharmacogenetic testing for depression in real-world clinical settings
... of pharmacogenetic-guided medica- tion management in a “real-world” ...of pharmacogenetic testing in a diverse set of clinical settings and health care ...of pharmacogenetic testing are ...
6
THE ROLE OF PHARMACIST IN DEVELOPMENT OF PHARMACOGENETIC TESTING AND IMPORTANT UPDATES OF PHARMACOGENOMICS
... The field of ‘pharmacogenetics’, which is ‘the study of variability in drug response due to heredity’, should help in reducing drug-caused morbidity and mortality. The recently coined term ‘pharmacogenomics’ usually ...
13
Pharmacogenetic testing revisited: 5′nuclease real-time polymerase chain reaction test panels for genotyping <em>CYP2D6 </em>and <em>CYP2C19</em>
... Abstract: Due to their involvement in the metabolization of commonly prescribed psychophar- maceutical drugs, the cytochrome oxidase genes CYP2D6 and CYP2C19 are extensive targets for pharmacogenetic ...
14
Pharmacogenetic testing affects choice of therapy among women considering tamoxifen treatment
... Although there is considerable controversy regarding the predictiveness of CYP2D6 genotypes on outcomes, there are alternatives to tamoxifen treatment. Aromatase inhibitors (AIs) are considered more effective at redu- ...
12
Pharmacogenetic testing through the direct-to-consumer genetic testing company 23andMe
... Pharmacogenetic testing for abacavir hypersensitivity is well-established, with the drug label stating “All pa- tients should be screened for the HLA-B*57:01 allele prior to initiating therapy” ...
8
Efficacy of prospective pharmacogenetic testing in the treatment of major depressive disorder: results of a randomized, double blind clinical trial
... of pharmacogenetic information to guide treatment selec- tion [5, ...of pharmacogenetic testing in psychiatry, informa- tion from different genes influencing pharmacokinetic and pharmacodynamic ...
13
Improving acceptance of pharmacogenetic testing in patient care
... PGx testing service into routine clinical care is feasible and produces clinically usable ...preemptive pharmacogenetic testing was considered a success ...prospective testing reduced the ...
299
Delivering pharmacogenetic testing in a primary care setting
... Abstract: Pharmacogenetic testing refers to a type of genetic test to predict a patient’s likelihood to experience an adverse event or not respond to a given ...this testing has been limited in many ...
8
<p>Physicians’ Attitudes and Ethical Obligations to Pharmacogenetic Testing</p>
... PGt testing can help physicians provide their patients with information about their probability to respond to a common medication such as simvastatin, besides, their increased risk of Alzheimer ’ s disease, which ...
10
The utility of pharmacogenetic testing to support the treatment of bipolar disorder
... The primary aim of this study was to identify at T0 (cor- responding to the test report communication) if the treatment prescribed by the psychiatrists in patients with a Clinical Glob[r] ...
8
Pharmacogenetic Testing: Effectiveness of the Use of the Indirect Anticoagulant Warfarin
... Thus, regardless of the use or refusal of Warfarin, the maximum number of bleeding cases during dental procedures occurs in patients from the 1st group who are [r] ...
10
Antidepressant prescribing in the precision medicine era: a prescriber’s primer on pharmacogenetic tools
... of pharmacogenetic decision support tools, such as increased remission rates [36, 46 – 48], reduced adverse effects [36, 49], and cost-savings [36, 50 – ...antidepressant pharmacogenetic testing is ...
7
CYP2B6*6, CYP2B6*18, Body weight and sex are predictors of efavirenz pharmacokinetics and treatment response: population pharmacokinetic modeling in an HIV/AIDS and TB cohort in Zimbabwe
... and pharmacogenetic factors as well as EFV- rifampicin drug interactions on EFV PK using population pharmacokinetic modeling in Zimbabwean patients with HIV/AIDS and TB ...grating pharmacogenetic ...
10
Analysis of pharmacogenetic traits in two distinct South African populations
... of pharmacogenetic variability in diverse populations is scarce, especially in sub-Saharan ...relevant pharmacogenetic traits in two distinct South African population ...of pharmacogenetic ...
18
Knowledge and attitude regarding pharmacogenetics among formerly pregnant women in the Netherlands and their interest in pharmacogenetic research
... ensure that the public is aware and understands this new concept. In particular, they first need to allow doc- tors to do pharmacogenetic testing before being pre- scribed certain drugs that are subjected ...
9
Pharmacogenetic evaluation to assess breakthrough psychosis with aripiprazole long acting injection: a case report
... mulation. Pharmacogenetic testing ruled out genetic al- teration that may influence drug metabolism, but noted that the patient carries a DRD2 -141C Del polymorph- ism (rs1799732), which may alter D2 ...
7
Pharmacogenomic considerations in opioid analgesia
... on pharmacogenetic testing in the context of pain therapies, genotyping of CYP isozymes is likely to become strongly ...on pharmacogenetic testing is more complex; though there was hope that ...
15
Pharmacogenetic information for patients on drug labels
... of pharmacogenetic informa- tion may have been excluded in this ...the pharmacogenetic information in older drug labels compared with more recently approved labels may differ due to differ- ent guidelines ...
9
Personalized medicines – are pharmacists ready for the challenge?
... (POC) pharmacogenetic testing an option for practice sites in which many do not have ready access to a certified laboratory and there are several POC testing devices now available (eg, Spartan RX and ...
11
Individualization of antiretroviral therapy
... Abstract: Antiretroviral therapy (ART) has evolved considerably over the last three decades. From the early days of monotherapy with high toxicities and pill burdens, through to larger pill burdens and more potent ...
17